Target intelligence / Profile preview

T-cell activation process

Molecular classification
Other
01

Overview

The **T-cell activation process** is a fundamental immunological event whereby T lymphocytes are functionally engaged in response to antigen presentation. Activation requires both signal 1 (antigen recognition by the T-cell receptor interacting with peptide–MHC complex on antigen-presenting cells) and signal 2 (co-stimulatory signals mediated by molecules such as CD28 engaging B7-1/B7-2 on APCs)[3][2]. This process triggers a complex signaling cascade involving protein tyrosine kinases (Lck, Fyn, ZAP-70), adaptor proteins (LAT, SLP-76), and signaling effectors that lead to transcription (NF-κB, NFAT, AP-1) promoting gene expression, cell proliferation, survival, differentiation, and cytokine production[1][4][6]. The immunological synapse, a molecular interface between T cell and APC, is crucial for maintaining and amplifying activation signaling[3][4]. Therapeutically, components of these pathways are targeted in various diseases, especially autoimmunity and transplantation, but direct targeting of the full process is not feasible—as it is not a single molecular entity but a biological ensemble of interactions[3][1].

Other names
T-cell activationT lymphocyte activationT cell primingT cell stimulationTCR activation
02

Mechanism of action

Blockade of co-stimulatory signals (e.g., CD28/B7 pathway), Antigen recognition inhibition, Depletion of activated T cells, Modulation of downstream signaling pathways (e.g., NFAT, NF-κB, MAPK activation, Ca2+ mobilization)[3][1]

03

Biological functions

Immune responseSignal transductionCell proliferationCytokine productionCell differentiationCell survival
04

Disease associations

CancerAutoimmune diseaseInfectionInflammationAllergyTransplant rejection
05

Safety considerations

Risk of general immunosuppression (infection, reactivation of latent viruses)Cytokine release syndromeAutoimmunityLoss of toleranceIncreased malignancy risk (with over-suppression)[3][1]
06

Interacting drugs

Abatacept

6 more in the full profile.

07

Biomarkers

Levels of activation markers (CD69, CD25, CD71)Cytokine production (IL-2, IFNγ, TNFα)Expression of activation-induced genesTCR clonality/expansionPhosphorylation of signaling molecules (ZAP-70, LAT, SLP-76)others[3][1]

Beyond the preview

Go deeper on T-cell activation process.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T-cell activation process.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call